Published in Pharm Res on January 01, 2006
Materials for diabetes therapeutics. Adv Healthc Mater (2012) 1.14
Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates. Bioconjug Chem (2010) 1.08
Approaches for enhancing oral bioavailability of peptides and proteins. Int J Pharm (2013) 1.01
Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects. Int J Mol Sci (2010) 0.94
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev (2015) 0.92
The artificial peroxidase activity of magnetic iron oxide nanoparticles and its application to glucose detection. Biomaterials (2009) 0.92
Regulation of the matrix microenvironment for stem cell engineering and regenerative medicine. Ann Biomed Eng (2011) 0.90
The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules. Biomaterials (2007) 0.89
Applications of microscale technologies for regenerative dentistry. J Dent Res (2009) 0.85
Anticancer and immunostimulatory role of encapsulated tumor antigen containing cobalt oxide nanoparticles. J Biol Inorg Chem (2013) 0.85
Size-tunable synthesis of stable superparamagnetic iron oxide nanoparticles for potential biomedical applications. J Biomed Mater Res A (2010) 0.84
Localization of magnetic pills. Proc Natl Acad Sci U S A (2011) 0.84
Surface-modified cobalt oxide nanoparticles: new opportunities for anti-cancer drug development. Cancer Nanotechnol (2012) 0.84
Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres. Biomagn Res Technol (2007) 0.83
Biodegradable, polymer encapsulated, metal oxide particles for MRI-based cell tracking. Magn Reson Med (2014) 0.77
In vitro evaluation of anticancer and antibacterial activities of cobalt oxide nanoparticles. J Biol Inorg Chem (2015) 0.77
Current overview on challenges in regenerative endodontics. J Conserv Dent (2015) 0.77
Pulsed magnetic field improves the transport of iron oxide nanoparticles through cell barriers. ACS Nano (2013) 0.77
Affinity-controlled protein encapsulation into sub-30 nm telodendrimer nanocarriers by multivalent and synergistic interactions. Biomaterials (2016) 0.75
Mechanoresponsive materials for drug delivery: Harnessing forces for controlled release. Adv Drug Deliv Rev (2016) 0.75
Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol (2007) 17.80
Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm (2008) 7.67
Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med (2008) 7.05
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A (2006) 6.90
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med (2012) 5.92
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature (2011) 4.57
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res (2004) 4.56
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials (2006) 4.09
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci U S A (2008) 3.80
Hydrogels in regenerative medicine. Adv Mater (2009) 3.80
Nanoparticle delivery of cancer drugs. Annu Rev Med (2011) 3.75
Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials (2010) 3.72
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci U S A (2008) 3.62
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev (2012) 3.34
Directed assembly of cell-laden microgels for fabrication of 3D tissue constructs. Proc Natl Acad Sci U S A (2008) 3.17
Passenger deletions generate therapeutic vulnerabilities in cancer. Nature (2012) 3.11
Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res (2013) 2.98
Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc (2007) 2.78
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano (2008) 2.76
Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci U S A (2009) 2.56
Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett (2007) 2.40
An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl (2006) 2.38
Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics (2012) 2.35
Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett (2010) 2.35
Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells. Lab Chip (2007) 2.30
Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators. ACS Nano (2013) 2.23
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials (2008) 2.21
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci U S A (2010) 2.21
Cell type-specific effects of Rb deletion in the murine retina. Genes Dev (2004) 2.18
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc Natl Acad Sci U S A (2011) 2.16
A cell-laden microfluidic hydrogel. Lab Chip (2007) 2.15
Micromolding of shape-controlled, harvestable cell-laden hydrogels. Biomaterials (2006) 2.12
A microwell array system for stem cell culture. Biomaterials (2007) 2.10
Directed 3D cell alignment and elongation in microengineered hydrogels. Biomaterials (2010) 1.94
Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J Am Chem Soc (2006) 1.94
Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew Chem Int Ed Engl (2008) 1.94
Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials (2005) 1.93
Modular Tissue Engineering: Engineering Biological Tissues from the Bottom Up. Soft Matter (2009) 1.93
Cell docking inside microwells within reversibly sealed microfluidic channels for fabricating multiphenotype cell arrays. Lab Chip (2005) 1.89
A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano (2010) 1.88
Nano/Microfluidics for diagnosis of infectious diseases in developing countries. Adv Drug Deliv Rev (2009) 1.87
A simple soft lithographic route to fabrication of poly(ethylene glycol) microstructures for protein and cell patterning. Biomaterials (2004) 1.84
Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett (2008) 1.80
Fabrication of gradient hydrogels using a microfluidics/photopolymerization process. Langmuir (2004) 1.76
Integrating microfluidics and lensless imaging for point-of-care testing. Biosens Bioelectron (2009) 1.74
Microfluidics for drug discovery and development: from target selection to product lifecycle management. Drug Discov Today (2007) 1.71
Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Acc Chem Res (2011) 1.71
Microfabricated biomaterials for engineering 3D tissues. Adv Mater (2012) 1.65
Polyanhydrides: an overview. Adv Drug Deliv Rev (2002) 1.64
Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proc Natl Acad Sci U S A (2010) 1.64
Functional Human Vascular Network Generated in Photocrosslinkable Gelatin Methacrylate Hydrogels. Adv Funct Mater (2012) 1.63
Controlling the porosity and microarchitecture of hydrogels for tissue engineering. Tissue Eng Part B Rev (2010) 1.61
Cell and protein compatibility of parylene-C surfaces. Langmuir (2007) 1.58
Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. ChemMedChem (2008) 1.57
Stop-flow lithography to generate cell-laden microgel particles. Lab Chip (2008) 1.57
Micromolding of photocrosslinkable chitosan hydrogel for spheroid microarray and co-cultures. Biomaterials (2006) 1.54
25th anniversary article: Rational design and applications of hydrogels in regenerative medicine. Adv Mater (2014) 1.52
Engineering microscale topographies to control the cell-substrate interface. Biomaterials (2012) 1.51
Controlled-size embryoid body formation in concave microwell arrays. Biomaterials (2010) 1.49
Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine (Lond) (2007) 1.47
Layer by layer three-dimensional tissue epitaxy by cell-laden hydrogel droplets. Tissue Eng Part C Methods (2010) 1.46
Carbon nanotube reinforced hybrid microgels as scaffold materials for cell encapsulation. ACS Nano (2011) 1.46
Microfluidic system for studying the interaction of nanoparticles and microparticles with cells. Anal Chem (2005) 1.45
Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo. J Am Chem Soc (2007) 1.45
Synthesis and characterization of tunable poly(ethylene glycol): gelatin methacrylate composite hydrogels. Tissue Eng Part A (2011) 1.44
Mechanically robust and bioadhesive collagen and photocrosslinkable hyaluronic acid semi-interpenetrating networks. Tissue Eng Part A (2009) 1.43
Fiber-based tissue engineering: Progress, challenges, and opportunities. Biotechnol Adv (2012) 1.42
New frontiers in nanotechnology for cancer treatment. Urol Oncol (2008) 1.42
Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. ChemMedChem (2007) 1.42
Amino alcohol-based degradable poly(ester amide) elastomers. Biomaterials (2008) 1.42
Biomimetic tissues on a chip for drug discovery. Drug Discov Today (2011) 1.41
Microfluidic technologies for accelerating the clinical translation of nanoparticles. Nat Nanotechnol (2012) 1.39
Digitally tunable physicochemical coding of material composition and topography in continuous microfibres. Nat Mater (2011) 1.38
Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells (2005) 1.38
Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery. Sci Transl Med (2013) 1.38
Molded polyethylene glycol microstructures for capturing cells within microfluidic channels. Lab Chip (2004) 1.38
Micropatterned cell co-cultures using layer-by-layer deposition of extracellular matrix components. Biomaterials (2005) 1.38
Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing. ACS Nano (2010) 1.35
Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups. Biomaterials (2009) 1.35
Nanoparticle technologies for cancer therapy. Handb Exp Pharmacol (2010) 1.35
Intracellular delivery of core-shell fluorescent silica nanoparticles. Biomaterials (2007) 1.35
Microfabrication of complex porous tissue engineering scaffolds using 3D projection stereolithography. Biomaterials (2012) 1.34
Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs. Lab Chip (2014) 1.34
pH-Responsive nanoparticles for drug delivery. Mol Pharm (2010) 1.33
Directed endothelial cell morphogenesis in micropatterned gelatin methacrylate hydrogels. Biomaterials (2012) 1.33
Nanotechnology and aptamers: applications in drug delivery. Trends Biotechnol (2008) 1.32